Diagnosis and monitoring of chronic viral hepatitis: serologic and molecular markers

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Chronic Hepatitis B (HBV), Hepatitis C (HCV), and Hepatitis D (HDV) infections are significant global health concerns.
• These viral infections can lead to severe liver conditions such as cirrhosis and hepatocellular carcinoma.
• Effective diagnosis and management strategies are essential for patient outcomes.

Purpose of the Study:

• To highlight the importance of serologic and molecular tools in managing chronic viral hepatitis.
• To emphasize the role of these tools in diagnosis, staging, and monitoring treatment response.
• To underscore the necessity of sensitive assays for assessing sustained virological response.

Main Methods:

• Review of existing serological markers for HBV diagnosis and staging.
• Discussion of molecular assays for pretreatment evaluation, drug response assessment, and mutant identification in HBV.
• Explanation of quantitative HCV RNA and HCV genotype testing for treatment management in HCV and HDV.

Main Results:

• Serological markers aid in HBV diagnosis and staging.
• Molecular assays are vital for evaluating treatment efficacy and identifying resistance in viral hepatitis.
• Sustained virological response, indicated by undetectable viral RNA, is the primary treatment endpoint.

Conclusions:

• Virological assays are indispensable for the accurate diagnosis and effective management of chronic HBV, HDV, and HCV infections.
• Sensitive molecular tools are critical for monitoring treatment and confirming sustained virological response.
• Comprehensive diagnostic and monitoring strategies are key to combating chronic viral hepatitis globally.